IP Library Granted Patent US 8,874,211
Granted Patent B2
US 8,874,211 · App. 12/968,797 · Granted Oct 28, 2014

Hypertension therapy based on activity and circadian rhythm

Inventors: Imad Libbus (St. Paul, MN); Andrew P. Kramer (Marine on St. Croix, MN)
Assignee: Cardiac Pacemakers, Inc.
A61N1/36135A61N1/36564A61N1/36117A61N1/3627
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,874,211
App. No.
12/968,797
Granted
Oct 28, 2014
Kind
B2
Abstract

According to an embodiment of a method for using an implantable device to deliver a hypertension therapy to a patient, an activity level is sensed using the implantable medical device. The implantable device may be programmed with a mapping of the sensed activity level to intensity levels for the hypertension therapy. The method may determine a desired intensity for the hypertension therapy as a function of both a circadian rhythm template and the sensed activity level, and use the implantable device to deliver the hypertension therapy using the desired intensity.

Claims (28)

1. A method for using an implantable device to deliver a hypertension therapy to a patient, comprising:

using the implantable device to sense an activity level, wherein the implantable device is programmed with a mapping of the sensed activity level to intensity levels for the hypertension therapy;

determining a desired intensity for the hypertension therapy as a function of both a circadian rhythm template and the sensed activity level; and

using the implantable device to deliver the hypertension therapy using the desired intensity.

2. The method of claim 1 , further comprising using sensed activity to generate the circadian rhythm template.

3. The method of claim 1 , wherein determining the desired intensity includes more aggressively changing the intensity level for changes in sensed activity level during a first time of day in comparison to a second time of day.

4. The method of claim 1 , wherein using the implantable device to deliver the hypertension therapy includes using the implantable medical device to deliver neural stimulation through an electrode to a neural target in an autonomic nervous system of the patient.

5. The method of claim 4 , wherein using the implantable medical device to deliver neural stimulation includes delivering a series of pulses with different burst durations or different burst duty cycles for different stimulation levels.

6. The method of claim 4 , wherein the sensed activity is associated with an undesired physiologic response, wherein using the implantable medical device to deliver neural stimulation includes adjusting the neural stimulation to abate the undesired physiologic response.

7. The method of claim 1 , further comprising comparing sensed activity to a reference parameter and using the comparison to determine the sensed activity level.

8. The method of claim 7 , wherein using the comparison includes determining a difference between the reference parameter and the sensed activity parameter to determine the sensed activity level.

9. The method of claim 1 , wherein sensing activity includes sensing heart rate, sensing respiration, sensing motion, sensing stroke volume, sensing tidal volume, sensing nerve activity, or sensing cardiac output.

10. The method of claim 1 , wherein sensing activity includes sensing motion, and sensing motion includes accounting for automotive movement.

11. The method of claim 1 , wherein determining the desired intensity for the hypertension therapy as a function of both a circadian rhythm template and the sensed activity level includes determining the desired intensity as a function of the circadian rhythm template and a difference between the sensed activity level and a reference activity parameter.

12. The method of claim 1 , wherein determining the desired intensity includes calculating the desired intensity from a mathematical formula.

13. The method of claim 1 , wherein determining the desired intensity includes using a look up table.

14. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a heart rate monitor to sense heart rate of the patient and to provide a signal indicative of a sensed heart rate level.

15. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a minute ventilation monitor to sense minute ventilation of the patient and to provide a signal indicative of a sensed minute ventilation level.

16. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a stroke volume monitor to sense stroke volume of the patient and to provide a signal indicative of a sensed stroke volume level.

17. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a respiration rate monitor to sense respiration rate of the patient and to provide a signal indicative of a sensed respiration rate level.

18. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a tidal volume monitor to sense tidal volume of the patient and to provide a signal indicative of a sensed tidal volume level.

19. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a nerve activity monitor to sense nerve activity of the patient and to provide a signal indicative of a sensed nerve activity level.

20. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a blood pressure monitor to sense blood pressure of the patient and to provide a signal indicative of a sensed blood pressure level.

21. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using a cardiac output monitor to sense cardiac output of the patient and to provide a signal indicative of a sensed cardiac output level.

22. The method of claim 1 , wherein using the implantable device to sense physiological activity of the patient includes using an accelerometer or EMG to monitor patient activity in addition to patient motion.

23. The method of claim 1 , wherein using the implantable device to deliver the hypertension therapy includes using the implantable medical device to deliver neural stimulation through an electrode to a vagus nerve.

24. The method of claim 1 , wherein using the implantable device to deliver the hypertension therapy includes using the implantable medical device to deliver neural stimulation through an electrode to a carotid sinus nerve.

25. The method of claim 1 , wherein using the implantable device to deliver the hypertension therapy includes using the implantable medical device to deliver neural stimulation through an electrode to a glossopharyngeal nerve.

Continuity (4)
Continuation 12840981 · Jul 21, 2010
Continuation 11558083 · Nov 9, 2006
Continuation In Part 10746864 · Dec 23, 2003
Related Publication 20110082514A1 · Apr 7, 2011